Assessment of peak inspiratory flow through dry powder inhalers in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers Source: Eur Respir J 2001; 18: 780-783 Year: 2001
Peak inspiratory flow (PIF) when using a dry powder inhaler in asthmatics and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001
Peak inspiratory flow rates in COPD patients with Easyhaler® dry powder inhaler Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients Source: Annual Congress 2012 - Asthma management Year: 2012
Peak inspiratory flow in COPD: implications for the use of dry powder inhalers Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Asthmatic children generate significantly different peak inspiratory flow rates (PIFR) through two different dry powder inhalers (DPI) Source: Eur Respir J 2003; 22: Suppl. 45, 494s Year: 2003
Peak inspiratory flow rate and the slope of the inhalation profile in dry powder inhalers (DPI) Source: Eur Respir J 2001; 18: Suppl. 33, 69s Year: 2001
Severe asthmatic patients generate significantly different peak inspiratory flows (PIF) through two different dry powder inhalers (DPI) Source: Eur Respir J 2004; 24: Suppl. 48, 308s Year: 2004
Selection of the dry powder inhaler based on peak inspiratory measurements in the preselected group of patients with bronchial obstruction Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001
In vitro performance characteristics of a novel multi-dose dry powder inhaler Airmax™ at different inspiratory flow rates Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002
Consider the turbulent energy not inhalation flow when patients use dry powder inhalers (DPIs) Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Peak inspiratory flow measured at different inhaler resistances in patients with asthma Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
COPD patients generate significantly different peak inspiratory flows (PIF) through two different dry powder inhalers (DPI) Source: Eur Respir J 2004; 24: Suppl. 48, 88s Year: 2004
Inspiratory profiles and consistency of behaviour regarding dose delivery characteristics of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004
Inspiratory profiles and resistance of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 291s Year: 2004
No differences in bronchodilation after inhalation of dry powder β2 -agonists in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 493s Year: 2001
In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003
Inspiratory flow patterns with dry powder inhalers (DPIs) of low and medium flow resistance in subjects with pulmonary arterial hypertension (PAH) Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020